Evaluation of phototoxic potential of gemifloxacin in healthy volunteers compared with ciprofloxacin

Chemotherapy

Volumn 45, Issue 6, 1999, Pages 512-520

  Vousden, Marika ^a,c   Ferguson, James ^b   Richards, Justin ^b   Bird, Nicholas ^a   Allen, Ann ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

^c Clinical Pharmacology Unit   (United Kingdom)

Author keywords

Ciprofloxacin; Fluoroquinolone; Gemifloxacin; Pharmacodynamics; Photosensitivity

Indexed keywords

CIPROFLOXACIN; GEMIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG SAFETY; ERYTHEMA; FEMALE; HUMAN; HUMAN EXPERIMENT; IRRADIATION; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PHOTOTOXICITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; SKIN MANIFESTATION; ULTRAVIOLET A RADIATION;

EID: 0032730502     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000007246     Document Type: Article

References (11)

1. Goldstein F, Bryskier A, Appelbaum PC, Bauernfeind A, Jacobs MR, Schito G-C, Wise R: The etiology of respiratory tract infections and the antibacterial activity of fluoroquinolones and other oral antibacterial agents against respiratory pathogens. Clin Microbiol Infect 1998;4(suppl2):2S8-2S18.
2. Moore T, Niconovich N, Coleman K: SB-265805 (LB20304a): In-vitro antibacterial activity against the common respiratory tract pathogens Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis. 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, 1998, San Diego, CA, USA. Poster F-098.
3. Critchley IA, Broskey J, Coleman K: SB-265805 (LB20304a): In-vitro activity, intracellular accumulation and killing of Legionella pneumophila in human macrophages. 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, 1998, San Diego, CA, USA. Poster F-100.
4. Smirnov A, Wellmer A, Gerber J, Maier K, Henne S, Nau R: Gemifloxacin is effective in experimental pneuroococcal meningitis. European Congress of Clinical Microbiology and Infectious Diseases, 1999, Berlin, Germany. Poster 223.
5. Allen A, Bygate E, Teillol-Foo M, Oliver S, Johnson M, Ward C: Pharmacokinetics and tolerability of gemifloxacin after administration of single oral doses to healthy volunteers; in: Abstracts from the 21st International Congress of Chemotherapy, Birmingham, UK. J Antimicrob Chemother 1999;44(suppl A): 137:Poster 440.
6. Allen A, Bygate E, Coleman K, McAllister P, Teillol-Foo M: In vitro activity and single dose pharmacokinetics of the (+)-and (-)-enantiomers of gemifloxacin; in: Abstracts from the 21st International Congress of Chemotherapy, Birmingham, UK. J Antimicrob Chemother 1999;44(suppl A):139:Poster 449.
7. Allen A, Bygate E, Teillol-Foo M, Oliver S, Johnson M, Ward C: Multiple-dose pharmacokinetics and tolerability of gemifloxacin following oral doses to healthy volunteers; in: Abstracts from the 21st International Congress of Chemotherapy, Birmingham, UK. J Antimicrob Chemother 1999;44(suppl A):133:Poster 418.
8. Ferguson J, Johnson BE: Ciprofloxacin-induced photosensitivity: In vitro and in vivo studies. Br J Dermatol 1990;123:9-20.
9. Fitzpatrick TR: The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol 1988;124:869-871.
10. Lipsky BA, Baler CA: Fluoroquinolone toxicity profiles: a review focusing on newer agents. Clin Infect Dis 1999;28:352-364.
11. Mirensky YM, Parish LC: Photosensitivity and the quinolones: review. J Eur Acad Dermatol Venereol 1995;4:1-4.